White label – Pompe disease - ClinicalTrials.eu

Safety and effectiveness study of DYNE-101 in patients with Myotonic Dystrophy Type 1 (DM1)

Not recruiting

2 1
Investigated Drugs:
- Humanised Igg1 Kappa Fragment Antibody Targeting Tfr1 Conjugated To P125 Oligonucleotide
Study on Esketamine for Long-term Pain Relief in Patients with Complex Regional Pain Syndrome

Not recruiting

3 1 1 1
Investigated Drugs:
- Esketamine Hydrochloride
Study on B-Cell Levels in Infants Exposed to Ocrelizumab During Pregnancy for Mothers with Multiple Sclerosis or Clinically Isolated Syndrome

Not recruiting

3 1 1 1
Investigated Diseases:
- Clinically isolated syndrome
- Multiple sclerosis
Investigated Drugs:
- Ocrelizumab
Study on the Effectiveness and Safety of OTL-203 for Patients with Hurler Syndrome (MPS-IH) Compared to Standard Treatment with Stem Cell Transplantation

Not recruiting

3 1 1 1
Investigated Diseases:
- Mucopolysaccharidosis I
Investigated Drugs:
Study of [177Lu]Lu-NeoB and Capecitabine for Patients with Advanced Breast Cancer Resistant to Hormone Therapy

Not recruiting

1 1 1 1
Investigated Diseases:
- Breast cancer metastatic
Investigated Drugs:
Study on Maribavir for Treating Cytomegalovirus in Children and Adolescents Post-Transplant

Not recruiting

3 1 1 1
Investigated Diseases:
- Infection in an immunocompromised host
Investigated Drugs:
- Maribavir
Study on the Effects of Navepegritide and Lonapegsomatropin in Children with Achondroplasia

Not recruiting

2 1 1
Investigated Diseases:
- Osteochondrodysplasia
Investigated Drugs:
- Lonapegsomatropin
Study on the Effects of AR1001 (Mirodenafil Dihydrochloride) for Patients with Early Alzheimer’s Disease

Not recruiting

3 1
Investigated Drugs:
- Mirodenafil Dihydrochloride
+2
Study of Farletuzumab Ecteribulin for Patients with Metastatic Non-Small Cell Lung Cancer After Previous Treatments

Not recruiting

2 1 1
Investigated Diseases:
- Non-small cell lung cancer
Investigated Drugs:
- Farletuzumab Ecteribulin
Study Comparing Rituximab and Zanubrutinib with Rituximab Alone for Untreated Patients with Splenic Marginal Zone Lymphoma

Not recruiting

3 1 1 1
Investigated Drugs:
- Rituximab
- Zanubrutinib
+1

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies